HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L’Oreal Must Stop Selling Harmful Hair Relaxers, Women’s Group Says As Lawsuits Stack Up

Executive Summary

Level Up, fighting for gender justice in the UK, says L’Oreal should reformulate or remove its hair relaxers from the market based on a US National Institutes of Health study indicating that frequent, long-term use of such products more than doubles risk of developing uterine cancer. Meanwhile the beauty giant is embroiled in numerous related lawsuits in federal courts around the US.

You may also be interested in...



Hair-Relaxer Litigation May Proceed In Illinois Federal Court, Judge Rules

US district judge Mary Rowland decided not to throw out the majority of plaintiffs’ claims against L’Oreal, Revlon, SoftSheen-Carson and other hair-relaxer marketers on 13 November. She says plaintiffs have sufficiently pleaded at this stage that defendants’ negligence resulted in their unknowingly using toxic chemical straightening products on their hair, leading to cancers or other injuries.

L’Oreal USA Faces First In Potential Wave Of Lawsuits Over Hair Straightener-Uterine Cancer Link

In her complaint against L’Oreal and other marketers of hair-smoothing products, plaintiff Jenny Mitchell, who was diagnosed with uterine cancer in August 2018, cites an NIH study published in October as “the first epidemiologic evidence of association between use of straightening products and uterine cancer.” She claims the defendants engaged in negligent or fraudulent practices in their marketing and sale of hair-straightening products that they knew posed dangers to users.

Over The Counter 1 March 2024: The Emerging Benefits Of ‘Beauty-From-Within,’ Featuring Kenvue’s Paul LaTerra

In this episode of Over the Counter, HBW Insight speaks to Paul LaTerra, Director, R&D, Global Hair and Scalp for Kenvue, a New Jersey-based consumer health company that markets skin care brands Neutrogena, Aveeno and Lubriderm. We discuss growth of the beauty-from-within supplements market, how the products complement topical skin care and hair formulas and the growing body of research demonstrating significant skin and hair health benefits. 

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153630

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel